Rockingstone Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Rockingstone Advisors's IBB Position: Q3 2026 in Review
Rockingstone Advisors held its iShares Biotechnology ETF (IBB) position steady in Q3 2026 at 3,185 shares worth $671K. The position accounts for 0.27% of the portfolio, ranked #75.
Rockingstone Advisors first reported a position in IBB in Q4 2022 and has held it in 16 quarters since. The position peaked at $1.21M in Q3 2024. 440 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Rockingstone Advisors held 3,185 shares of iShares Biotechnology ETF worth $671K as of Q3 2026.
- Rockingstone Advisors left its iShares Biotechnology ETF share count unchanged in Q3 2026.
- iShares Biotechnology ETF made up 0.27% of Rockingstone Advisors's portfolio in Q3 2026, its #75 holding.
- Rockingstone Advisors first reported a position in iShares Biotechnology ETF in Q4 2022 and has held it in 16 quarters since.
- Rockingstone Advisors's iShares Biotechnology ETF position peaked at $1.21M in Q3 2024.
- 440 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Rockingstone Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.